May 12-15, 2025
Congress Center Hamburg | Hamburg, Germany

We’re heading to Hamburg! Demeetra will be on site at BioProcess International Europe 2025, one of the most influential gatherings for bioprocessing leaders, innovators, and scientists driving the future of biologics.

Our CEO, Jack Crawford, will be in attendance, ready to connect with partners and peers across the biomanufacturing space. If you’re exploring novel approaches to gene editing, cell line development, or scalable cell engineering platforms, Jack would love to hear about your latest challenges and share how Demeetra’s technologies may help.

We’re also proud to share that Cintia Gomez Limia, PhD, one of our scientists, will be presenting original research during the conference.

This is a great opportunity to learn more about the unique advantages of Demeetra’s platform technologies, including Cas-CLOVER, our precise CRISPR-Cas9 alternative, and Harbor-IN, our license free transposase system designed for efficient cell line engineering.

Let’s make time to meet in Hamburg and talk about how we can move science forward together.

Demeetra provides integrated genome engineering platforms, and products, backed by deep technical expertise.

Contact us to learn how our differentiated IP, flexible access models, and internal know-how can support adoption from discovery through bioprocessing and commercial use.